HopeStage
Back to all studies
CompletedEUCTR 2008-001417-26

Double blind, randomized, placebo-controlled, mulitcentric clinical trial to evaluate the relapse prevention of a hypericum extract in outdoor patients with moderate depressive episodes (major depr...

This historical record does not confirm current site availability.

Historical research recordGermanyDepression
The study in practice

Understand this study

What did researchers investigate?

This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments. Check the source details below for country statuses and any transfer to CTIS.

Listed locations
Germany
Study phase
Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.

Get this study by email

HopeStage may email me about this study.
Loading the security check...
Study clarity

Study information

Study start dateNot clearly listed
Recruitment status
Completed
Enrollment listed in the registry
Not clearly listed
Sponsor
Steigerwald Arzneimittelwerk GmbH
Sponsor type
Other organization
Study type
Biological
Intervention type
Biological
Study phase
Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.
Locations
Germany
Age range
Not clearly listed
Official registry ID
EUCTR 2008-001417-26
Official title
Show the full official title

Double blind, randomized, placebo-controlled, mulitcentric clinical trial to evaluate the relapse prevention of a hypericum extract in outdoor patients with moderate depressive episodes (major depr...

Looking for a study you can join?

Explore recruiting studies

Recruitment & locations

Completed

Germany

Registry details
Historical country statuses

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is Steigerwald Arzneimittelwerk GmbH.

Want to explore more studies?

Explore studies